Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Long-Term Deferred Tax (2016 - 2020)

Tenax Therapeutics' Long-Term Deferred Tax history spans 3 years, with the latest figure at $41325.0 for Q4 2017.

  • On a quarterly basis, Long-Term Deferred Tax fell 26.44% to $41325.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $41325.0, a 26.44% decrease, with the full-year FY2017 number at $41325.0, down 26.44% from a year prior.
  • Long-Term Deferred Tax hit $41325.0 in Q4 2017 for Tenax Therapeutics, down from $56180.0 in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for TENX hit a ceiling of $56180.0 in Q4 2016 and a floor of $19151.0 in Q4 2015.
  • Historically, Long-Term Deferred Tax has averaged $38885.3 across 3 years, with a median of $41325.0 in 2017.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 193.35% in 2016 and later dropped 26.44% in 2017.
  • Tracing TENX's Long-Term Deferred Tax over 3 years: stood at $19151.0 in 2015, then skyrocketed by 193.35% to $56180.0 in 2016, then dropped by 26.44% to $41325.0 in 2017.
  • Business Quant data shows Long-Term Deferred Tax for TENX at $41325.0 in Q4 2017, $56180.0 in Q4 2016, and $19151.0 in Q4 2015.